| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8715207 | Journal of the American Academy of Dermatology | 2018 | 31 Pages |
Abstract
An understanding of the molecular basis of inflammation in rare cutaneous disorders can lead to targeted therapy, which promises to be more beneficial than broad immunosuppressants.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Amy S. MSc, MD, Tali MD, MSc, Yael MD, Kristen MD, Thy MD, Muriel MB, BCh, Maeve A. MB, BCh, Gary MD, Gabrielle C. MD, Alan D. MD, DSc, Emma MD, PhD,